Medical Properties Trust: A $680 Million Reality Check

Medical Properties Trust demonstrates real-world asset value with $680 million in Q3 cash proceeds from hospital and Infracore sales. Recent hospital sales achieved 60–72% gains over original investments, supporting MPT’s ability to monetize assets above book value. Proceeds are earmarked for debt reduction, improving leverage and partially offsetting FFO/AFFO headwinds from higher refinancing rates. MPT trades at a 53% discount to book value; the current valuation appears disconnected from portfolio monetization evidence.

Medical Properties Trust ( MPT ) is a battleground stock, which I have covered thirteen times in recent years. I'm not here to discuss the Q2 2026 results, since these have been talked about a couple of This article was written by Luuk Wierenga 1.7K Followers Follow I'm Luuk Wierenga, an economics teacher from the Netherlands with a strong passion for income investing. As a REIT specialist I specialize in identifying Real Estate Investment Trusts (REITs) that are temporarily out-of-favor with Mr. Market. I use fundamental economic insights to assess the true intrinsic value of a stock. My investment horizon is long-term, and my strategy revolves around contrarian and deep-value opportunities. I also contribute to the investing group High Dividend Opportunities led by Rida Morwa and a team of other top Seeking Alpha income investing analysts. The service focuses on sustainable income through a variety of high yield investments with a targeted safe +9% yield. Features include: model portfolio with buy/sell alerts, preferred and baby bond portfolios for more conservative investors, vibrant and active chat with access to the service’s leaders, dividend and portfolio trackers, and regular market updates. The service philosophy focuses on community, education, and the belief that nobody should invest alone.